Search & Analyze

Mahamaya Lifesciences Ltd.

ChemicalsPesticides & Agrochemicals

www.mahamayalifesciences.com/home BSE: 544611

₹175.90BSE2.55%

17 Sep, 4:01 PM

₹175.90

₹418 Cr

25.28

3.67

34.94%

₹180.50

₹175.80

₹205.05

₹111.00

Customise metrics bar

Price Performance

Peer Comparison

Name
UPL UPL	554.35	23.03	46,796.53	1.09	-73.00	58.52%	10,181.00	10.47%	12.00
PI INDUS.LTD PIIND	2,308.00	29.50	35,016.54	0.66	244.20	-38.95%	1,702.30	-10.43%	16.00
SUMICHEM SUMICHEM	457.00	39.11	22,810.96	0.29	214.51	20.45%	1,063.35	0.62%	23.39
BAYER CROP BAYERCROP	3,891.00	319.96	17,486.97	3.80					22.36
SHARDACROP SHARDACROP	742.60	10.74	6,699.77	2.01	88.02	-38.36%	1,073.77	9.03%	31.10
DHAN AGRI DHANUKA	988.70	14.31	4,407.46	0.21	75.50	27.94%	442.02	20.01%	29.41
RALLIS INDIA RALLIS	204.40	23.99	3,974.94	1.48	-14.15	-274.26%	507.54	7.70%	13.53
Mahamaya Lifesciences Ltd.	175.90	25.28	417.66	0.00					26.23

Quarterly Results

consolidated figures in ₹ Crores · Quarterly

Particulars

Profit & Loss

consolidated figures in ₹ Crores · Annual

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)
No of Months	12.00	12.00	12.00	12.00
INCOME :
	89.91	137.08	161.57	264.15
	89.91	137.08	161.57	264.15
EXPENDITURE :
Increase/Decrease in Stock	-13.67	1.11	-16.55	-9.27
Raw Material Consumed	86.76	115.05	152.58	227.80
Power & Fuel Cost	0.08	0.22	0.38	0.66
Employee Cost	2.96	2.90	3.14	5.19
Other Manufacturing Expenses	1.18	1.74	2.28	6.36
General and Administration Expenses	3.66	4.98	5.08	7.82
Selling and Distribution Expenses	1.92	1.05	0.78	1.83
Miscellaneous Expenses	0.68	0.89	0.41	0.51
	83.57	127.94	148.10	240.90
Operating Profit (Excl OI)	6.34	9.13	13.47	23.25
	0.24	0.32	1.26	3.02
	6.58	9.46	14.73	26.27
Interest	1.90	3.09	6.13	7.14
PBDT	4.68	6.37	8.60	19.13
	0.96	1.27	1.48	1.77
Profit Before Taxation & Exceptional Items	3.72	5.10	7.12	17.36
	3.72	5.10	7.12	17.36
Provision for Tax	1.00	1.35	1.90	4.42
	2.72	3.75	5.22	12.94
Consolidated Net Profit	2.72	3.75	5.22	12.94
Profit Balance B/F	11.74	14.43	18.18	23.40
Appropriations	14.46	18.18	23.40	36.34
	21.81	30.03	41.79	7.29
Adjusted EPS	1.98	2.73	3.80	7.29

Balance Sheet

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)
	1.25	1.25	1.25	17.77
Total Reserves	14.46	18.19	23.41	31.66
Reserve excluding Revaluation Reserve	14.46	18.19	23.41	31.66
Revaluation reserve	0.00	0.00	0.00	0.00
	15.71	19.44	24.66	49.42
Secured Loans	8.91	9.75	7.69	6.16
Unsecured Loans	0.77	0.56	0.86
Deferred Tax Assets / Liabilities	-0.10	0.17	0.39	0.71
Long Term Provisions	0.31	0.31	0.35	0.44
Total Non-Current Liabilities	9.89	10.78	9.29	7.31
Trade Payables	16.56	27.65	22.66	55.07
Other Current Liabilities	4.18	6.90	7.54	10.04
Short Term Borrowings	7.87	11.56	43.34	48.83
Short Term Provisions	1.41	1.56	4.58	17.68
Total Current Liabilities	30.02	47.66	78.12	131.62
Total Liabilities	55.61	77.88	112.07	188.35
Gross Block	20.39	23.37	24.61	31.33
Less: Accumulated Depreciation	2.50	3.35	4.14	4.91
Net Block	17.89	20.02	20.47	26.42
Long Term Investment	0.00	0.00	0.00	0.00
Long Term Loans & Advances	0.33	0.33	0.33	0.45
Other Non Current Assets	0.00	0.00	0.00	0.00
Total Non-Current Assets	22.28	23.88	24.75	31.62
Inventories	18.63	34.78	51.02	100.21
Sundry Debtors	9.11	9.53	28.31	48.46
Cash and Bank	1.37	3.04	3.01	3.99
Other Current Assets	0.11	0.15	0.24	0.53
Short Term Loans and Advances	4.11	6.50	4.73	3.53
Total Current Assets	33.32	54.00	87.32	156.73
Net Current Assets (Including Current Investments)	3.31	6.34	9.20	25.11
Total Assets	55.61	77.88	112.07	188.35
Contingent Liabilities				1.85
Total Debt	19.17	24.37	54.63	58.11
	125.77	155.67	197.46	27.82
Adjusted Book Value	11.43	14.15	17.95	27.82

Cash Flow

consolidated figures in ₹ Crores

Particulars	FY 2021-22 (Mar)	FY 2022-23 (Mar)	FY 2023-24 (Mar)	FY 2024-25 (Mar)
No of Months	12.00	12.00	12.00	12.00
	3.72	5.10	7.12	17.36
Adjustment	2.82	4.65	6.66	7.58
Changes In working Capital	-3.17	-7.62	-35.34	-22.15
Cash Flow after changes in Working Capital	3.37	2.12	-21.57	2.80
Cash Flow from Operating Activities	2.16	1.07	-22.66	0.52
Cash Flow from Investing Activities	-3.25	-2.79	-2.00	-8.28
Cash Flow from Financing Activitie	1.38	2.35	24.35	8.52
Net Cash Inflow / Outflow	0.29	0.63	-0.31	0.77
Opening Cash & Cash Equivalents	0.49	0.77	1.40	1.09
Closing Cash & Cash Equivalent	0.77	1.40	1.09	1.85

Ratios

Valuation

25.28

3.67

13.77

1.27

7.06

48.58

Profitability

34.94

26.23

8.62

8.80

4.90

Leverage & Liquidity

1.18

1.19

3.43

Returns

0.00

1.76

Shareholding Pattern

Numbers in percentages

Particulars	Nov '25	Mar '26
	56.35	56.35
	11.06	7.29
	32.59	36.36
	43.65	43.65
No. of Shareholders	1,034	584

Corporate Actions

Showing: All

Date	Type	Details	Ex-Date	Record Date
2026-09-08	AGM
2026-05-20	Board Meeting	Half Yearly Results & Audited Results

Insider Trading

Date	Person	Category	Transaction Type	Shares	Value (₹)
2026-09-14	PRASHANT KRISHNAMURTHY	Market	Buy	4,800
2026-09-14	PRASHANT KRISHNAMURTHY	Market	Buy	2,400

Sector Overview

ChemicalsPesticides & Agrochemicals

Mahamaya Lifesciences Ltd. operates in the Chemicals sector under the Pesticides & Agrochemicals industry. This sector is one of the key drivers of the Indian economy and is closely tracked by the relevant Nifty sectoral index.

Company Profile

Corporate information and contact details

Key Management

6 members across the board and senior leadership

Krishnamurthy Ganesan

Managing Director

₹79.09 L

Mar '25

Prashant Krishnamurthy

Executive Director

₹1.11 Cr

Mar '25

Lalitha Krishnamurthy

Whole Time Director

₹59.17 L

Mar '25

Charudatta Digambar Mayee

Non Executive Independent Director

—

Gopal Krishna Raju

Non Executive Independent Director

—

Sekhar Kavasseri Rajagopalan

Non Executive Independent Director

—

Latest News

News

No news found for Mahamaya Lifesciences Ltd..

₹175.90

-2.55%